Physical Activity, Functional Capacity and Quality of Life in Older Patients With Chronic Comorbidities
Comparison of Physical Activity, Functional Capacity and Quality of Life Between Older Patients With Chronic Comorbidities and Healthy Peers
Comparison of Physical Activity, Functional Capacity and Quality of Life Between Older Patients With Chronic Comorbidities and Healthy Peers
Sponsor study identifier
observational
148
1 country
1
Study Start
January 1, 2024
Actual (reported)Primary Completion
June 30, 2024
Actual (reported)Study Completion
June 30, 2024
Actual (reported)The prevalence of obesity, hypertension (HT) and type 2 diabetes (T2D) is increasing. The adoption of an increasingly sedentary lifestyle is one of the main factors contributing to the increased incidence of chronic diseases such as obesity, cardiovascular diseases, HT and T2D. Furthermore, lack of physical activity leads to a decline in functional capacity in these individuals, which facilitates the progression of HTN, T2D and obesity. The presence of multiple chronic comorbidities can exacerbate the negative impact on health-related quality of life. The main aim of this study was to compare the levels of physical activity, functional capacity and quality of life between elderly individuals with chronic comorbidities such as HTN, T2D and obesity and their healthy peers. Quality of life, functional capacity , and physical activity level will be assessed by SF-36 questionnaire, 6-minute walk test, and the International Physical Activity Questionnaire-short form, respectively.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2024
Actual (reported)June 30, 2024
Actual (reported)June 30, 2024
Actual (reported)July 25, 2024
Actual (reported)August 2, 2024
Actual (reported)Level of Physical Activity
Physical activity will be assessed by SF-36 questionnaire. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
10-15 minutes
Level of Functional Capacity
The 6-minute walking test will be used to assess the functional capacity. Participants will be recorded in a 30-meter straight corridor for 6 minutes at their own walking speed, as fast as possible but without running. The walking distance will be recorded in meters.
15-20 minutes
Level of Quality of Life
Quality of life will be assessed by the International Physical Activity Questionnaire-short form. (IPAQ-SF). The IPAQ scoring protocol assigns the following MET values to walking, moderate, and vigorous intensity activity: 3.3 METs, 4.0 METs, and 8.0 METs, respectively. If the participants reported at least 150 min/wk of walking, moderate, or vigorous intensity physical activity.
8-10 minutes
Older patients with obesity
Older patients with hypertension
Older patients with type 2 diabetes
Healthy older adults
Thirty-seven patients with obesity Thirty-seven patients with hypertension Thirty-seven patients with type 2 diabetes Thirty-seven healthy older adults
Istanbul Atlas University
Istanbul, Kaguthane, 34408, Turkey (Türkiye)
Hikmet Ucgun, PT, PhD
Atlas University
148 participants (actual enrollment reported by the registry).
First Submitted
July 25, 2024
First Posted
August 2, 2024
Study Start
January 1, 2024
Actual (reported)Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2024
Actual (reported)Study Completion
June 30, 2024
Actual (reported)Last Updated
August 2, 2024
Record last verified: 2024-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: